Sinergi Multi Lestarindo Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Sinergi Multi Lestarindo Tbk. trades at Rp144 (market cap 344.57B, 9.46M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 33.9× Sinergi Multi Lestarindo Tbk.'s market cap, and Sinergi Multi Lestarindo Tbk. is more actively traded (9.46M versus 429.7K). Which is the better fit depends on your goals.
| SMLE | TSPC | |
|---|---|---|
Market Cap | 344.57B | 11.68T |
Volume | 9.46M | 429.7K |
Lot | 94.62K | 4.3K |
Turnover | 1.36B | 1.11B |
Average Price | 143.3 | 2,591.65 |
Value | 1.36B | 1.11B |
Indicative Equilibrium Price | 144 | 2,580 |
Indicative Equilibrium Volume | 140 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.
Read more on SMLE →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →